Replies to post #3657 on PROTALIX BIOTHERAPEUTICS, INC. (PLX)

[jcon777]

Today is the day we waited for.

Patience has paid off.

[Kronberg]

"Of the patients that completed the trial, 69 have opted, with the advice of the treating physician, to continue receiving PRX–102 1 mg/kg every other week in a long-term open-label extension study."

So from 77 patients which were treated 69 or ~90 % are on PRX-102 now.
The total sale of Fabrazyme and Replagal today is about $1.6-1.7B, I wonder how much of this money will be the revenue of Chiesi and Protalix In a couple of years.